Miach Orthopaedics announced today that the FDA cleared an expanded indication for the company’s Bear implant for ACL tears. The Bear implant previously won novo approval to treat skeletally mature patients at least 14 years of age with complete ACL tears. Now, the FDA granted 510(k) clearance to expand the indication to include children and […]
Miach Orthopedics
Miach Orthopedics names Arjun Ishwar as VP of sales and marketing
Miach Orthopedics today announced it appointed Arjun Ishwar as VP of sales and marketing. Ishwar brings experience in corporate strategic planning and execution, sales and marketing leadership and commercialization to the Westborough, Massachusetts-based company. He will lead Miach’s commercialization efforts for the Bridge-Enhanced ACL Restoration (BEAR) Implant, which launched in the U.S. in fall 2021. […]
Miach Orthopaedics makes ACL tear implant commercially available in U.S.
Miach Orthopaedics announced today that it made the BEAR implant for treating anterior cruciate ligament (ACL) tears commercially available in the U.S. Westborough, Massachusetts–based Miach designed the BEAR (Bridge-Enhanced ACL Restoration) implant to enable the healing of a patient’s torn ACL, shifting from the current standard of care that includes reconstruction that replaces the ACL […]
Miach Orthopedics names new CFO, board member
Miach Orthopedics this week announced that it has appointed Christopher Joyce as VP and chief financial officer and has appointed Kevin Sidow to the board of directors. Joyce will be responsible for leading financial operations. He has more than 30 years of experience in finance and most recently served as consulting CFO for several biotech […]
